WebTetsu Tomonari's 54 research works with 300 citations and 1,814 reads, including: A case of complete response with rechallenge-lenvatinib plus transcatheter arterial … WebAbstract. Lenvatinib is a multi-targeted tyrosine kinase inhibitor available for the treatment of unresectable hepatocellular carcinoma (HCC). We herein report an 84-year-old-man with interstitial pneumonia caused by lenvatinib. Four months after the start of lenvatinib administration for HCC, chest computed tomography revealed bilateral ground ...
Therapeutic efficacy of lenvatinib in nonviral unresectable ...
Web10 ott 2024 · Aim. Cabozantinib (CAB), a multiple kinase inhibitor, has been approved for use in patients with previously treated unresectable hepatocellular carcinoma (uHCC). … Web15 gen 2024 · Search worldwide, life-sciences literature Search. Advanced Search crunchyroll hs
专利检索_ .外壳专利检索_ .外壳专利检索查询_ .外壳专利检索查询 …
Web16 ott 2024 · Tetsu Tomonari 1 , Yasushi Sato 1 , Hironori Tanaka 1 , Takahiro Tanaka 1 , Tatsuya Taniguchi 1 , Masahiro Sogabe 1 , Koichi Okamoto 1 , Hiroshi Miyamoto 1 , … WebTetsu Tomonari; Fumika Nakamura; Yasuteru Fujino; Yasuhiro Mitsui; Hiroshi Miyamoto; Naoki Muguruma; Akinori Morita; Hitoshi Ikushima; Tetsuji Takayama; Journal of Gastroenterology. Published on 14 Jul 2024. 0 views XX downloads; XX citations; WebTetsu Tomonari and Yasushi Sato contributed equally to this work. 1Department of Gastroenterology and Oncology, Tokushima University Graduate School of Biomedical … crunchyroll iframe player 1.2.1